Engineered Cardiac Tissues as a Platform for CRISPR‐Based Mitogen Discovery is a research paper published in Advanced Healthcare Materials (2024). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Heart, Lung, and Blood Institute
Grant: F31HL162460
National Heart, Lung, and Blood Institute
Grant: F31HL156453
National Heart, Lung, and Blood Institute
Grant: U01HL134764
National Heart, Lung, and Blood Institute
Grant: R01HL164013
School of Medicine, Duke University
Grant: Translating Duke Health
American Heart Association
Grant: 903369
NHLBI NIH HHS
Grant: U01 HL156348
NIGMS NIH HHS
Grant: T32 GM144291
NIBIB NIH HHS
Grant: U01 EB028901
NIBIB NIH HHS
Grant: R01 EB032726
FWCI
0.00
Citation Percentile
0.2%
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals